J. Tillner
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 13
- HER2/EGFR in Cancer Research 7
- Colorectal Cancer Treatments and Studies 6
- Cancer Treatment and Pharmacology 4
- Pancreatic and Hepatic Oncology Research 3
-
- Lung Cancer Treatments and Mutations 7
- Co-authors
- Federico Rojo (7 shared papers)Dirk Weber (8 shared papers)Lenore Teichert (3 shared papers)N. Schleucher (4 shared papers)Tanja Trarbach (4 shared papers)U. Vanhoefer (4 shared papers)José Baselga (2 shared papers)A. Harstrick (1 shared paper)
- Journals
- Journal of Clinical Oncology (13 papers)Obesity (2 papers)Journal of Nuclear Medicine (2 papers)Diabetes Obesity and Metabolism (2 papers)Pharmaceuticals (1 paper)
- Partner nations
- GermanyUnited StatesSweden
In The Last Decade
J. Tillner
29 papers receiving 892 citations
Peers
Comparison fields: 5 of 68
- Endocrinology, Diabetes and Metabolism 254
- Oncology 385
- Pulmonary and Respiratory Medicine 241
- Otorhinolaryngology 22
- Radiology, Nuclear Medicine and Imaging 99
Countries citing papers authored by J. Tillner
This map shows the geographic impact of J. Tillner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Tillner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Tillner more than expected).
Fields of papers citing papers by J. Tillner
This network shows the impact of papers produced by J. Tillner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Tillner. The network helps show where J. Tillner may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Tillner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 232 | |
| 2 | 2018 | 138 | |
| 3 | 2006 | 87 | |
| 4 | 2006 | 83 | |
| 5 | 2014 | 79 | |
| 6 | 2020 | 35 | |
| 7 | 2004 | 35 | |
| 8 | 2021 | 26 | |
| 9 | 2023 | 23 | |
| 10 | 2002 | 21 | |
| 11 | 2021 | 18 | |
| 12 | 2004 | 14 | |
| 13 | 2004 | 14 | |
| 14 | 2005 | 14 | |
| 15 | 2004 | 11 | |
| 16 | 2020 | 10 | |
| 17 | 2005 | 9 | |
| 18 | 2015 | 8 | |
| 19 | 2005 | 8 | |
| 20 | 2005 | 8 |
About J. Tillner
J. Tillner is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 29 papers that have together received 917 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (7 papers), Lung Cancer Treatments and Mutations (7 papers), HER2/EGFR in Cancer Research (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Cancer Treatment and Pharmacology (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Neuroblastoma Research and Treatments (3 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (254 citations), Oncology (385 citations), Pulmonary and Respiratory Medicine (241 citations), Otorhinolaryngology (22 citations) and Radiology, Nuclear Medicine and Imaging (99 citations). J. Tillner has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Federico Rojo, Dirk Weber, Lenore Teichert, N. Schleucher, Tanja Trarbach, U. Vanhoefer, José Baselga, A. Harstrick, Mitra Tewes and Oliver Rosen. Their work appears in journals such as Journal of Clinical Oncology, Obesity, Journal of Nuclear Medicine, Diabetes Obesity and Metabolism and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.